Cabbacis Inc (CABI)

Cabbacis Granted U.S. Patent for Vaporizer Pods Containing Tobacco and Hemp. Click here to learn more: https://lnkd.in/dRmqcgqQ $CABI $XXII $PM $BTI $MO

Cabbacis Provides First Half 2025 Corporate Update. https://www.cabbacis.com/press-viewer?i=157926 $CABI

We're excited to feature Cabbacis ($CABI) as a participating company at the Noble Capital Markets Emerging Growth Virtual Equity Conference, October 8-9. Don't miss the chance to explore unique investment opportunities. 1x1 Meetings available for qualified investors. 📅 Register: https://www.meetmax.com/sched/event_125441/investor_reg_new.html?attendee_role_id=NOBLE_INVESTOR #NobleConference #EmergingGrowth #InvestorEvent

Cabbacis Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program Link here: https://www.cabbacis.com/press-viewer?i=150408 $CABI

Cabbacis Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program. Details here: https://www.cabbacis.com/press-viewer?i=150408 #MZGroup #IR #Investors $CABI

Cabbacis has been granted a new U.S. patent for its vaporizer pods—now holding patents in 31 countries. This adds to its IP leadership in harm-reduction products combining tobacco & hemp. Details here: https://www.cabbacis.com/press#b2iLibScrollTo #Patents #Tobacco #Hemp #HarmReduction #iBlend $CABI

Clinical trial results are in: Cabbacis’ patented iBlend™ cigarettes significantly reduced cravings for usual brand cigarettes – while the 20% hemp version cut Carbon Monoxide compared with non-hemp options. A promising step for harm reduction. Read here: https://www.cabbacis.com/press#b2iLibScrollTo #Tobacco #HarmReduction #ReducedNicotine $CABI